Literature DB >> 22204333

Structure-function relationships of iodinated contrast media and risk of nephrotoxicity.

P Stratta1, M Quaglia, A Airoldi, S Aime.   

Abstract

Characteristics of CM have greatly changed over time. First-generation ionic CM have many-fold (5-7) greater osmolalities than plasma. Subsequently non ionic CM generations were looked for to reduce osmolality, and encompass nonionic monomers and nonionic dimers reaching osmolality as low as that of plasma (iso-osmolar CM) but paying however dear, as viscosity is considerably increased. Intrarenal microcirculation has its "Achilles" heel in the outer medulla, where the smallness of capillary lumen and the slackness of the capillary mesh render regular blood flow at high risk, mainly because it is the same area in which the only renal work needing oxygen is made and? Iodinated CM may exert their nephrotoxic effects in three different ways: by interfering with vascular hemodynamics, by interfering with intratubular fluid volume and composition, and by producing direct cytotoxic effects to glomerular and tubular cells due to iodine by-itself. Furthermore, effects of oxygen free radical can damage glomerular cells by increasing the permeability and tubular cells impairing specific function and leading to apoptosis. Although clinical nephrotoxicity has considerably improved over time, there is no evidence for an a priori superiority of a specific CM. In general, low-osmolar (2-3 times blood) and iso-osmolar (the same as blood) CM are recommended, keeping in mind that within last generation CM dimeric iso-somolar compounds reach viscosity values higher than monomeric low-osmolar compounds and hyperviscosity is a neglected mechanisms of nephrotoxicity. We suggest that CM should be classified not only by osmolality, but also by viscosity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22204333     DOI: 10.2174/092986712798992084

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  12 in total

1.  Impact of contrast agent viscosity on coronary balloon deflation times: bench testing results.

Authors:  Owen Mogabgab; Vishal G Patel; Tesfaldet T Michael; Anna Kotsia; George Christopoulos; Subhash Banerjee; Emmanouil S Brilakis
Journal:  J Interv Cardiol       Date:  2014-01-23       Impact factor: 2.279

Review 2.  Understanding and preventing contrast-induced acute kidney injury.

Authors:  Michael Fähling; Erdmann Seeliger; Andreas Patzak; Pontus B Persson
Journal:  Nat Rev Nephrol       Date:  2017-01-31       Impact factor: 28.314

3.  Clinical value and feasibility of CT pulmonary angiography with personalized injection of contrast agent in pulmonary embolism.

Authors:  Zhiming Tang; Kun Fan; Lanyu Qiu; Likang Chen; Qilin Qian; Ting Zhang; Yi Wang; Menglong Han; Chengjian Deng; Weihong He
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

4.  Letter to the Editor re: Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections?

Authors:  Piero Stratta; Cristina Izzo; Caterina Canavese; Marco Quaglia
Journal:  Eur Radiol       Date:  2013-02-01       Impact factor: 5.315

5.  Clinically useful dilution factors for iodine and gadolinium contrast material: an animal model of pediatric digital subtraction angiography using state-of-the-art flat-panel detectors.

Authors:  John M Racadio; Soumya R Kashinkunti; Rami A Nachabe; Judy M Racadio; Neil D Johnson; Kamlesh U Kukreja; Manish N Patel; Mary Beth Privitera; Jasmine E Hales; Todd A Abruzzo
Journal:  Pediatr Radiol       Date:  2013-06-05

6.  Effects of iodinated contrast agents on renal oxygenation level determined by blood oxygenation level dependent magnetic resonance imaging in rabbit models of type 1 and type 2 diabetic nephropathy.

Authors:  Jia-huan Wang; Ke Ren; Wen-Ge Sun; Li Zhao; Hong-shan Zhong; Ke Xu
Journal:  BMC Nephrol       Date:  2014-09-02       Impact factor: 2.388

7.  Intra-arterial and intravenous applications of Iosimenol 340 injection, a new non-ionic, dimeric, iso-osmolar radiographic contrast medium: phase 2 experience.

Authors:  Karoline Meurer; Michael Laniado; Norbert Hosten; Bettina Kelsch; Barry Hogstrom
Journal:  Acta Radiol       Date:  2014-06-17       Impact factor: 1.990

Review 8.  Contrast media viscosity versus osmolality in kidney injury: lessons from animal studies.

Authors:  Erdmann Seeliger; Diana C Lenhard; Pontus B Persson
Journal:  Biomed Res Int       Date:  2014-02-23       Impact factor: 3.411

Review 9.  Interference of medical contrast media on laboratory testing.

Authors:  Giuseppe Lippi; Massimo Daves; Camilla Mattiuzzi
Journal:  Biochem Med (Zagreb)       Date:  2014-02-15       Impact factor: 2.313

10.  The pharmacokinetic profile, tolerability and safety of the iodinated, non-ionic, dimeric contrast medium Iosimenol 340 injection in healthy human subjects.

Authors:  Karoline Meurer; Bettina Kelsch; Barry Hogstrom
Journal:  Acta Radiol       Date:  2014-06-03       Impact factor: 1.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.